Oncopeptides is Pharmaceuticals in Sweden that focus on oncopeptide AB business. Founded in 2000. They cover business area such as oncopeptide AB, drug, cancer, Ygalo, a peptide, alkylator, Peptidase Enhanced Compounds, Melflufen, an effective treatment, particular multiple myeloma, well result, melflufen, patient, physician, this serious disease.
2000
( 24 years old in 2024 )
Oncopeptide AB
-
Luntmakargatan 46, 7th floor
111 37 Stockholm
Sweden
Private
oncopeptide ABdrugcancerYgaloa peptidealkylatorPeptidase Enhanced CompoundsMelflufenan effective treatmentparticular multiple myelomawell resultmelflufenpatientphysicianthis serious disease
* We use standard office opening hours in near Oncopeptides's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Oncopeptides is Pharmaceuticals business from Sweden that founded in 2000 (24 years old in 2024), Oncopeptides business is focusing on Oncopeptide AB.
Oncopeptides headquarter office and corporate office address is located in Luntmakargatan 46, 7th floor 111 37 Stockholm Sweden.
Oncopeptides was founded in Sweden.
In 2024, Oncopeptides is currently focus on oncopeptide AB sector.
Above is snippet of Google Trends for "oncopeptide AB" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Oncopeptides, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
